Furthermore, blocking miR-7 with antagomiR-7 corrected the increased differentiation of B cells to plasma cells, a biological process mediated by regulation of the PTEN/AKT signalling pathway, while inhibiting disease activity in lupus (Wang et al., 2020). This evidence concerns the gene AKT1 and systemic lupus erythematosus.